Developer docs
API playgroundTry for free, no card

Search company profiles

Triangle Insights Group

Full company profile

uuid000aob1

Namestring
Triangle Insights Group
Legal namestring
Triangle Insights Group Incorporated
Company typeenum
Private
Founded yearint
2018
Descriptiontext

Triangle Insights Group is a boutique strategy consulting firm focused exclusively on the life sciences industry, headquartered in Durham, North Carolina with offices in San Francisco and New York. The firm operates as a subsidiary of Valeris under the brand 'Triangle Insights Group by Valeris' following a 2026 integration, and it draws on affiliated platforms such as Policy Reporter for policy and reimbursement intelligence. Its core technology consists of analytical and advisory capabilities built on therapeutic area expertise, primary market research methodologies, claims data analysis, and proprietary frameworks — there is no proprietary software platform.

The firm offers four core service lines: Brand Strategy & Commercialization, Corporate Strategy & Due Diligence, Pricing & Market Access, and New Product Planning. It serves enterprise pharmaceutical companies, biotechnology companies, and private equity investors, delivering senior-led consulting engagements spanning commercial assessment, launch strategy (75+ launches supported), pricing and market access, due diligence (75+ M&A transactions), and new product planning (100+ pre-commercial assets supported). The firm maintains centers of excellence in Pricing & Market Access, Cell & Gene Therapy, and New Product Planning.

Triangle Insights Group generates revenue through billable consulting engagements under fixed-fee or time-and-materials models, with no subscription or SaaS products. Go-to-market relies on direct senior-led business development through professional networks, industry conferences, referrals, and inbound demand generated by a steady cadence of white papers, case studies, and blog content. The firm claims global reach across all areas of life sciences despite its U.S.-only office footprint.

Short descriptiontext

Triangle Insights Group is a boutique life sciences strategy consulting firm serving pharmaceutical, biotech, and private equity clients with services spanning brand strategy, pricing and market access, due diligence, and new product planning, now operating as a Valeris subsidiary.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersDurham, United States
HQ citystring
Durham
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices3 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
life sciences consulting, pharmaceutical strategy consulting, biotech commercialization consulting, pricing and market access, commercial due diligence
Industry3 codes
PRIMARYBPAHACAA
Strategy & Corporate Development Consulting
SECONDARYBPAHADAA
Corporate Strategy Advisory
SECONDARYBPAHAOAA
M&A Advisory (Buy-Side & Sell-Side)
NAICS code3 codes
  • Management Consulting Services54161
  • Other Management Consulting Services541618
  • Other Scientific and Technical Consulting Services54169
SIC code2 codes
  • Services-Management Consulting Services8742
  • Services-Engineering, Accounting, Research, Management8700
Product category
Life Sciences Strategy Consulting
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model1 record
1Strategy Consulting Engagements
TypeProfessional Services
Description

Triangle Insights Group generates revenue through billable consulting engagements with pharmaceutical, biotech, and private equity clients. Engagements span commercial assessment, brand strategy, pricing and market access, new product planning, and corporate strategy/due diligence. Projects are typically scoped as fixed-fee engagements or time-and-materials engagements led by senior consultants and partners. The firm does not appear to offer subscription or SaaS products.

triangleinsightsgroup.com
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components4 values
Personnel, Marketing or Sales, Operations, Infrastructure
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

Triangle Insights Group is a life sciences strategy consulting firm that provides strategic guidance to pharmaceutical companies, biotechnology firms, and private equity investors. Its core offerings span four service lines—Brand Strategy & Commercialization, Corporate Strategy & Due Diligence, Pricing & Market Access, and New Product Planning—covering commercial assessment, brand strategy, launch excellence, pricing and market access, payer engagement, and transaction diligence across the pharmaceutical product lifecycle.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 5 values shown
  • Triangle Insights Group has participated in 75+ pharmaceutical brand launches
+4 more records
Product overview1 text field

Triangle Insights Group is a premier strategy consulting firm offering life sciences consulting services. The company operates as a unified consulting practice providing four core service lines: Brand Strategy & Commercialization, Corporate Strategy & Due Diligence, Pricing & Market Access, and New Product Planning. These services work together to provide end-to-end strategic guidance across the pharmaceutical lifecycle, from early pipeline assessment through commercialization and lifecycle management. The firm has participated in 75+ product launches, supported 100+ pre-commercial assets, conducted 200+ commercial assessments, and completed 75+ M&A transactions. The company also publishes white papers and insights as part of its thought leadership offering.

Product and service4 records
1Brand Strategy & Commercialization
CategoryPharma Brand Strategy & Commercialization Consulting
Description

Consulting service focused on strategic brand planning, positioning, message testing, competitive strategy, and launch excellence for pharmaceutical and biotech companies. The firm has participated in 75+ launches and supports demand forecasts, go-to-market models, and organizational design.

2Corporate Strategy & Due Diligence
CategoryPharma Corporate Strategy & Due Diligence Consulting
Description

Consulting service for pharmaceutical companies and private equity investors to conduct commercial diligence for investments, including portfolio strategy, R&D prioritization, opportunity identification, growth strategy, and transaction support for M&A and licensing.

3Pricing & Market Access
CategoryPharma Pricing & Market Access Consulting
Description

Consulting service providing pricing strategy, market access planning, value proposition development, and payer engagement strategies. Includes GTN forecasting, revenue preservation strategies, evidence generation benchmarking, and lifecycle management.

4New Product Planning
CategoryPharma New Product Planning Consulting
Description

Strategic planning consulting to help clients maximize value for new pharmaceutical products. Covers commercial assessment, target product profile development, patient journey mapping, indication strategy, evidence generation planning, and market-shaping strategies.

Scale indicator11 records

Each record includes

Type, Value, Description, Source

Partnership2 partners
Strategic tierCoreTypeTechnology or Integration
Description

Triangle Insights Group collaborates closely with Policy Reporter, an affiliated platform under the Valeris parent company, to incorporate real-time policy and reimbursement intelligence into its pricing and market access consulting engagements. This partnership enables the firm to offer clients insights informed by the latest regulatory and payer developments, strengthening the accuracy and timeliness of market access strategy recommendations.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Triangle Insights Group operates as a business unit within Valeris, a parent company that delivers integrated life sciences and pharmaceutical commercialization services. Valeris provides the broader technology, data analytics, and operational infrastructure (including Policy Reporter) that Triangle Insights Group leverages to power its consulting engagements. The firm is branded as 'Triangle Insights Group by Valeris.'

Recent move1 record

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Putnam Associates is a boutique life sciences strategy consulting firm offering commercial strategy, market access, pricing, and due diligence services to pharma and biotech clients - the closest direct competitor to Triangle Insights Group in scale, therapeutic focus, and service mix.

TypeDirect peer
Description

Lumanity is a life sciences consulting firm built around commercialization strategy, new product planning, and evidence generation. It directly competes with Triangle Insights Group for biopharma commercial assessment and launch excellence engagements.

3ZS Associates
TypeDirect peer
Description

ZS Associates is a large global consulting firm with a deeply established pharma and biotech practice spanning commercial strategy, launch, pricing/market access, and analytics - a scaled direct competitor with overlapping service lines to Triangle's four core offerings.

TypeDirect peer
Description

Syneos Health Consulting is the consulting arm of Syneos Health and traces its roots to Campbell Alliance, a leading life sciences consulting firm. It directly competes with Triangle Insights Group in biopharma commercial strategy, launch, and due diligence work.

TypeDirect peer
Description

CRA's Life Sciences practice provides strategy, economics, and litigation support to pharma, biotech, and medical product clients. It is a direct competitor in commercial assessments, pricing/market access strategy, and transaction diligence.

TypeBroad incumbent
Description

IQVIA is a global life sciences services and analytics leader with a large consulting arm spanning commercial strategy, market access, and real-world evidence. It competes with Triangle Insights Group across multiple service lines as a much larger incumbent.

TypeBroad incumbent
Description

BCG operates a top-tier global biopharma strategy practice covering commercial strategy, launch, and M&A advisory. Several Triangle Insights Group leaders previously worked at BCG, and BCG remains a significant incumbent competitor.

TypeBroad incumbent
Description

McKinsey's Pharma & Medical Products practice provides commercial strategy, launch excellence, and corporate strategy services to the largest global pharma clients, representing a key incumbent competitor across Triangle's offering.

TypeBroad incumbent
Description

Real Chemistry is a healthcare-focused advisory and communications firm with acquired strategy consulting assets (formerly Boston Healthcare Associates). It competes with Triangle Insights Group in commercial diligence and market access work for life sciences clients.

TypeDirect peer
Description

Health Advances is a boutique life sciences strategy consulting firm serving pharma, biotech, and medtech clients with commercial assessments, new product planning, and transaction due diligence - a closely comparable direct peer to Triangle Insights Group.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers3 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles17 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries1 record

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance2 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Triangle Insights Group

Life Sciences Strategy Consultingtriangleinsightsgroup.com

Triangle Insights Group is a boutique life sciences strategy consulting firm serving pharmaceutical, biotech, and private equity clients with services spanning brand strategy, pricing and market access, due diligence, and new product planning, now operating as a Valeris subsidiary.

What Triangle Insights Group does

Triangle Insights Group is a boutique strategy consulting firm focused exclusively on the life sciences industry, headquartered in Durham, North Carolina with offices in San Francisco and New York. The firm operates as a subsidiary of Valeris under the brand 'Triangle Insights Group by Valeris' following a 2026 integration, and it draws on affiliated platforms such as Policy Reporter for policy and reimbursement intelligence. Its core technology consists of analytical and advisory capabilities built on therapeutic area expertise, primary market research methodologies, claims data analysis, and proprietary frameworks — there is no proprietary software platform.

The firm offers four core service lines: Brand Strategy & Commercialization, Corporate Strategy & Due Diligence, Pricing & Market Access, and New Product Planning. It serves enterprise pharmaceutical companies, biotechnology companies, and private equity investors, delivering senior-led consulting engagements spanning commercial assessment, launch strategy (75+ launches supported), pricing and market access, due diligence (75+ M&A transactions), and new product planning (100+ pre-commercial assets supported). The firm maintains centers of excellence in Pricing & Market Access, Cell & Gene Therapy, and New Product Planning.

Triangle Insights Group generates revenue through billable consulting engagements under fixed-fee or time-and-materials models, with no subscription or SaaS products. Go-to-market relies on direct senior-led business development through professional networks, industry conferences, referrals, and inbound demand generated by a steady cadence of white papers, case studies, and blog content. The firm claims global reach across all areas of life sciences despite its U.S.-only office footprint.

Triangle Insights Group firmographics

Firmographics
Name
Triangle Insights Group
Legal name
Triangle Insights Group Incorporated
Website
https://triangleinsightsgroup.com
Company type
Private
Founded year
2018
Operating status
Operating
Headcount range
11–50 employees
Short description
Triangle Insights Group is a boutique life sciences strategy consulting firm serving pharmaceutical, biotech, and private equity clients with services spanning brand strategy, pricing and market access, due diligence, and new product planning, now operating as a Valeris subsidiary.
Ownership category
akta.pro rank

Triangle Insights Group industry classification

Industry
Product category
Life Sciences Strategy Consulting
NAICS
Management Consulting Services (54161), Other Management Consulting Services (541618), Other Scientific and Technical Consulting Services (54169)
SIC
Services-Management Consulting Services (8742), Services-Engineering, Accounting, Research, Management (8700)
akta.pro industry
PRIMARYBPAHACAA
Strategy & Corporate Development Consulting
SECONDARYBPAHADAA
Corporate Strategy Advisory
SECONDARYBPAHAOAA
M&A Advisory (Buy-Side & Sell-Side)

Keywords

  • Life sciences consulting
  • Pharmaceutical strategy consulting
  • Biotech commercialization consulting
  • Pricing and market access
  • Commercial due diligence

Where Triangle Insights Group is headquartered

Location

Headquarters

HQ city
Durham
HQ country
United States
HQ region
North America

Offices3 records

Markets served

Triangle Insights Group business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Marketing or Sales, Operations, Infrastructure

Revenue model

  1. Strategy Consulting Engagements: Triangle Insights Group generates revenue through billable consulting engagements with pharmaceutical, biotech, and private equity clients. Engagements span commercial assessment, brand strategy, pricing and market access, new product planning, and corporate strategy/due diligence. Projects are typically scoped as fixed-fee engagements or time-and-materials engagements led by senior consultants and partners. The firm does not appear to offer subscription or SaaS products.

Go-to-market motion2 records

Distribution channels1 record

Marketing channels6 records

Triangle Insights Group product offering

Product offering

Core offering

Triangle Insights Group is a life sciences strategy consulting firm that provides strategic guidance to pharmaceutical companies, biotechnology firms, and private equity investors. Its core offerings span four service lines—Brand Strategy & Commercialization, Corporate Strategy & Due Diligence, Pricing & Market Access, and New Product Planning—covering commercial assessment, brand strategy, launch excellence, pricing and market access, payer engagement, and transaction diligence across the pharmaceutical product lifecycle.

Product overview

Triangle Insights Group is a premier strategy consulting firm offering life sciences consulting services. The company operates as a unified consulting practice providing four core service lines: Brand Strategy & Commercialization, Corporate Strategy & Due Diligence, Pricing & Market Access, and New Product Planning. These services work together to provide end-to-end strategic guidance across the pharmaceutical lifecycle, from early pipeline assessment through commercialization and lifecycle management. The firm has participated in 75+ product launches, supported 100+ pre-commercial assets, conducted 200+ commercial assessments, and completed 75+ M&A transactions. The company also publishes white papers and insights as part of its thought leadership offering.

Differentiator

Problem solved

Functional benefit

Products and services

  • Brand Strategy & Commercialization Consulting service focused on strategic brand planning, positioning, message testing, competitive strategy, and launch excellence for pharmaceutical and biotech companies. The firm has participated in 75+ launches and supports demand forecasts, go-to-market models, and organizational design.
  • Corporate Strategy & Due Diligence Consulting service for pharmaceutical companies and private equity investors to conduct commercial diligence for investments, including portfolio strategy, R&D prioritization, opportunity identification, growth strategy, and transaction support for M&A and licensing.
  • Pricing & Market Access Consulting service providing pricing strategy, market access planning, value proposition development, and payer engagement strategies. Includes GTN forecasting, revenue preservation strategies, evidence generation benchmarking, and lifecycle management.
  • New Product Planning Strategic planning consulting to help clients maximize value for new pharmaceutical products. Covers commercial assessment, target product profile development, patient journey mapping, indication strategy, evidence generation planning, and market-shaping strategies.

Quantifiable outcome

  • Triangle Insights Group has participated in 75+ pharmaceutical brand launches
  • +4 more outcomes

Companies that use Triangle Insights Group

Customer profile

Named customers3 records

Segments3 records

Ideal customer profiles2 records

Triangle Insights Group technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Triangle Insights Group partnerships and signals

Strategic signal

Partnerships

Two partnerships are on record, tiered core.

  • Policy ReportercoreTechnology or IntegrationTriangle Insights Group collaborates closely with Policy Reporter, an affiliated platform under the Valeris parent company, to incorporate real-time policy and reimbursement intelligence into its pricing and market access consulting engagements. This partnership enables the firm to offer clients insights informed by the latest regulatory and payer developments, strengthening the accuracy and timeliness of market access strategy recommendations.
  • ValeriscoreStrategic or Co-development PartnerTriangle Insights Group operates as a business unit within Valeris, a parent company that delivers integrated life sciences and pharmaceutical commercialization services. Valeris provides the broader technology, data analytics, and operational infrastructure (including Policy Reporter) that Triangle Insights Group leverages to power its consulting engagements. The firm is branded as 'Triangle Insights Group by Valeris.'

Scale indicators11 records

Recent moves1 record

Expansion highlights5 records

Triangle Insights Group competitors and assessment

Company assessment

Direct peers

  • Putnam Associates: Putnam Associates is a boutique life sciences strategy consulting firm offering commercial strategy, market access, pricing, and due diligence services to pharma and biotech clients - the closest direct competitor to Triangle Insights Group in scale, therapeutic focus, and service mix.
  • Lumanity (formerly Defined Health): Lumanity is a life sciences consulting firm built around commercialization strategy, new product planning, and evidence generation. It directly competes with Triangle Insights Group for biopharma commercial assessment and launch excellence engagements.
  • ZS Associates: ZS Associates is a large global consulting firm with a deeply established pharma and biotech practice spanning commercial strategy, launch, pricing/market access, and analytics - a scaled direct competitor with overlapping service lines to Triangle's four core offerings.
  • Syneos Health Consulting (formerly Campbell Alliance): Syneos Health Consulting is the consulting arm of Syneos Health and traces its roots to Campbell Alliance, a leading life sciences consulting firm. It directly competes with Triangle Insights Group in biopharma commercial strategy, launch, and due diligence work.
  • Charles River Associates (Life Sciences Practice): CRA's Life Sciences practice provides strategy, economics, and litigation support to pharma, biotech, and medical product clients. It is a direct competitor in commercial assessments, pricing/market access strategy, and transaction diligence.
  • Health Advances: Health Advances is a boutique life sciences strategy consulting firm serving pharma, biotech, and medtech clients with commercial assessments, new product planning, and transaction due diligence - a closely comparable direct peer to Triangle Insights Group.

Broad incumbents

  • IQVIA (Consulting & Analytics): IQVIA is a global life sciences services and analytics leader with a large consulting arm spanning commercial strategy, market access, and real-world evidence. It competes with Triangle Insights Group across multiple service lines as a much larger incumbent.
  • Boston Consulting Group (Biopharma practice): BCG operates a top-tier global biopharma strategy practice covering commercial strategy, launch, and M&A advisory. Several Triangle Insights Group leaders previously worked at BCG, and BCG remains a significant incumbent competitor.
  • McKinsey & Company (Pharma & Medical Products practice): McKinsey's Pharma & Medical Products practice provides commercial strategy, launch excellence, and corporate strategy services to the largest global pharma clients, representing a key incumbent competitor across Triangle's offering.
  • Real Chemistry (formerly W2O): Real Chemistry is a healthcare-focused advisory and communications firm with acquired strategy consulting assets (formerly Boston Healthcare Associates). It competes with Triangle Insights Group in commercial diligence and market access work for life sciences clients.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

Triangle Insights Group social profiles

Digital presence

Triangle Insights Group compliance and trust

Trust signal

Compliance2 records

Triangle Insights Group financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Triangle Insights Group leadership team

Management profile

Number of profiles

Profiles17 records

Triangle Insights Group subsidiaries and ownership

Company hierarchy

Subsidiaries1 record

Triangle Insights Group funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Triangle Insights Group M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Triangle Insights Group

What does Triangle Insights Group do?

Triangle Insights Group is a life sciences strategy consulting firm that provides strategic guidance to pharmaceutical companies, biotechnology firms, and private equity investors. Its core offerings span four service lines—Brand Strategy & Commercialization, Corporate Strategy & Due Diligence, Pricing & Market Access, and New Product Planning—covering commercial assessment, brand strategy, launch excellence, pricing and market access, payer engagement, and transaction diligence across the pharmaceutical product lifecycle.

Is Triangle Insights Group a public or private company?

Triangle Insights Group is a private company. It is classified as corporate owned and is currently operating.

When was Triangle Insights Group founded?

Triangle Insights Group was founded in 2018. It employs 11 to 50 people.

Where is Triangle Insights Group based?

Triangle Insights Group is headquartered in Durham, United States, in the North America region.

How does Triangle Insights Group make money?

One revenue line is on record: strategy Consulting Engagements.

Who are Triangle Insights Group's main competitors?

Direct peers on record are Putnam Associates, Lumanity (formerly Defined Health), ZS Associates, Syneos Health Consulting (formerly Campbell Alliance), Charles River Associates (Life Sciences Practice) and Health Advances. Broad incumbents are IQVIA (Consulting & Analytics), Boston Consulting Group (Biopharma practice), McKinsey & Company (Pharma & Medical Products practice) and Real Chemistry (formerly W2O).

Does Triangle Insights Group have an API?

No public API is recorded for Triangle Insights Group.

What industry is Triangle Insights Group in?

Triangle Insights Group's product category is Life Sciences Strategy Consulting. Its primary akta.pro industry code is BPAHACAA, Strategy & Corporate Development Consulting, with a secondary code of BPAHADAA, Corporate Strategy Advisory. Its NAICS code is 54161 and its SIC code is 8742.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
PR NewswireTRIANGLE INSIGHTS GROUP BY VALERIS ANNOUNCES APPOINTMENT OF ERIN SOLANO TO PARTNERTriangle Insights Group by Valeris announced the appointment of Erin Solano to Partner, effective immediately. Solano brings extensive experience in life sciences consulting, including market access strategy, commercial strategy, and business development, having previously served as Managing Director for Syneos Health Consulting. The company stated her expertise will support Triangle's short- and long-term growth objectives.YahooMERCALIS AND TRIANGLE INSIGHTS GROUP ANNOUNCE SENIOR LEADERSHIP APPOINTMENTSTriangle Insights Group, acquired by Mercalis in April 2022, named Aileen Nicoletti and Michael Turner as partners to expand product strategy and launch capabilities. Nicoletti brings over 20 years of experience, while Turner has over 25 years and has supported over 75 global launches.PR NewswireMERCALIS AND TRIANGLE INSIGHTS GROUP ANNOUNCE SENIOR LEADERSHIP APPOINTMENTSTriangle Insights Group, acquired by Mercalis in April 2022, named Aileen Nicoletti and Michael Turner as partners to expand product strategy and launch capabilities. Nicoletti brings over 20 years of experience, while Turner has over 25 years and supported over 75 global launches. The appointments strengthen the firm's leadership team.PR NewswireMERCALIS AND TRIANGLE INSIGHTS GROUP ANNOUNCE EXECUTIVE LEADERSHIP APPOINTMENTSMercalis and Triangle Insights Group announced executive appointments, naming Rohit Kumar as Executive Vice President and General Manager and promoting Chris Apolito as Chief Strategy Officer. Kumar brings nearly 20 years of life sciences consulting experience, while Apolito has over 25 years in pharmaceutical and strategy consulting.PR NewswireTRIANGLE INSIGHTS GROUP ANNOUNCES PROMOTION OF SARAH JIMSTriangle Insights Group, a life sciences strategy consulting firm headquartered in Durham, North Carolina, has promoted Sarah Jims from Senior Principal to Partner. Jims joined the firm in August 2014 and specializes in commercial assessment, portfolio strategy, and cell and gene therapy advisory services for biotech and pharmaceutical clients. The firm was acquired by TrialCard Incorporated in April 2022, strengthening its position within the life sciences commercialization sector.PR NewswireTRIANGLE INSIGHTS GROUP STRENGTHENS NEW YORK TEAM WITH HIRING OF NEW PRINCIPALTriangle Insights Group, a life sciences consulting firm headquartered in Durham, North Carolina, announced the appointment of Heather Martin to Principal, strengthening its New York City office and senior leadership team. Martin brings 15 years of experience in biotechnology, pharmaceuticals, and healthcare strategy, having previously served as Associate Principal at Eversana Consulting and Director at Syneos Health Consulting. The firm stated that her expertise will bolster its presence in the Philadelphia/New York/Boston corridor.PR NewswireTRIANGLE INSIGHTS GROUP ANNOUNCES SENIOR LEADERSHIP PROMOTIONSTriangle Insights Group, a life sciences strategy consulting firm headquartered in Durham, North Carolina, announced the promotions of Megan Thomas and Ryan Coe from Senior Principals to Partners. Thomas leads the firm's New Product Planning and Pricing and Market Access areas, while Coe heads Commercial Assessment and Due Diligence, including portfolio analysis and partnering support with private equity and life sciences companies. The firm, which was acquired by TrialCard Incorporated in April 2022, cited both executives' consistent excellence in client delivery and thought leadership as justification for the promotions.PR NewswireTRIALCARD RELEASES 2022 ANNUAL HIGHLIGHTSTrialCard Incorporated announced its 2022 annual highlights, showcasing significant growth and performance improvements, particularly through the acquisition of Triangle Insights Group and record growth in its TC Script pharmacy division. The company continues to enhance its capabilities in life sciences commercialization, while also advocating for policies that support patients. These developments position TrialCard for further value delivery to its substantial client base in 2023 and beyond.PR NewswireTRIALCARD ANNOUNCES ACQUISITION OF TRIANGLE INSIGHTS GROUPTrialCard Incorporated announced the acquisition of Triangle Insights Group, a strategy consulting firm specializing in life sciences commercialization. This transaction marks TrialCard's seventh acquisition since partnering with Odyssey Investment Partners in 2017 and aims to combine strategic insights with operational execution for biopharmaceutical clients. All employees from Triangle Insights Group will be retained by TrialCard following the deal.PrwebTriangle Insights Group Announces Key Leadership PromotionsTriangle Insights Group promoted Ryan Coe and Megan Thomas to Principal, joining the senior leadership team. Coe brings portfolio strategy and data analytics experience, while Thomas, a founding employee, has delivered client excellence in commercial strategy and pricing. The firm, a life sciences consulting company, cited their contributions to growth.